MARIA CECILIA PAREDES: Open Payments
NPI 1255956546 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,364 in 65 payments from 27 companies in 2025. Trend: 2023 $153 · 2024 $2,227 · 2025 $2,364
Food & beverage: $1,981Education: $383
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $501 |
| AstraZeneca Pharmaceuticals LP | 8 | $359 |
| Daiichi Sankyo Inc. | 9 | $167 |
| Tempus AI, Inc | 2 | $154 |
| Incyte Corporation | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $125 |
| GENZYME CORPORATION | 2 | $98 |
| Madrigal Pharmaceuticals | 1 | $97 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| Merck Sharp & Dohme LLC | 3 | $65 |
Products named: ENHERTU, XT CDX, CALQUENCE, Monjuvi, Trodelvy, REZDIFFRA, Xospata, REBLOZYL.
Industry payments across CA — which companies pay providers there.
